Fig. 6From: Calnexin, an ER-induced protein, is a prognostic marker and potential therapeutic target in colorectal cancerGene silencing of calnexin attenuates HCT116 colon cancer cell survival. Western blot analysis depicting decreased expression of calnexin in HCT116 colon cancer cells following transfection for 24 h with calnexin siRNA compared with control siRNA (a). Sample image of a clonogenic survival assay and histogram depicting total colony number following transfection of HCT116 cells with control or calnexin siRNA for 24 h and subsequent colony formation for a further 14 days (b; n = 3). Annexin V and PI staining of HCT116 cells transfected with control or calnexin siRNA for 24 h followed by treatment with 5FU (20 µg/ml) for 48 h as determined by flow cytometry (c, *p < 0.05 versus HCT116 cells transfected with control siRNA and treated with 5FU; d, **p < 0.01 versus HCT116 cells transfected with control siRNA and treated with vehicle, ###p < 0.001 versus HCT116 cells transfected with calnexin siRNA and treated with vehicle; E, **p < 0.01 versus HCT116 cells transfected with control siRNA and treated with 5FU; graphs representative of three independent experiments)Back to article page